A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses.
Npj Vaccines
Arbelaez, Carlos A CA; Estrada, Juan J; Gessner, Melissa A MA; Glaus, Charles C; Morales, Agnieszka B AB; Mohn, Deanna D; Phee, Hyewon H; Lipford, J Russell JR; Johnston, James A JA
Mutant MHC class II epitopes drive therapeutic immune responses to cancer.
Nature
Kreiter, Sebastian S; Vormehr, Mathias M; van de Roemer, Niels N; Diken, Mustafa M; Löwer, Martin M; Diekmann, Jan J; Boegel, Sebastian S; Schrörs, Barbara B; Vascotto, Fulvia F; Castle, John C JC; Tadmor, Arbel D AD; Schoenberger, Stephen P SP; Huber, Christoph C; Türeci, Özlem Ö; Sahin, Ugur U